Candriam Equities L Biotechnology Class C USD Dis

Register to Unlock Ratings
Morningstar Rating™(Relative to Category)31/03/2024
 Morningstar ReturnMorningstar RiskMorningstar Rating™
3-YearAbove AverageBelow Average5 star
5-YearAbove AverageBelow Average5 star
10-YearAbove AverageBelow Average4 star
OverallAbove AverageBelow Average5 star
 
Click here to see our Methodology
1 Year Daily Volatility Chart (annualised)
  • Candriam Equities L Biotechnology Class C USD Dis
  • Morningstar Gbl Biotechnology NR USD
%
Volatility Measurements30/04/2024
 
3-Yr Std Dev15.97 %
3-Yr Mean Return5.18 %
 
3-Yr Sharpe Ratio0.16
 
Modern Portfolio Statistics30/04/202430/04/2024
 Standard IndexBest Fit Index
 Morningstar Gbl Biotechnology NR USD  Morningstar Gbl Biotechnology NR USD
3-Yr Beta0.840.84
3-Yr Alpha-2.47-2.47
 
Advertisement
In order to provide consistency across the report data provided by different Asset Managers, the calculated data points presented are generated using Morningstar’s proprietary calculation methodology which is set out in more detail at(https://www.morningstar.com/research/signature)
© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures